Clinical Trial

Extreme Morphology and Metabolic Health

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Researchers at the University of Bath are investigating the metabolism of individuals with extreme body size, including those with skeletal dysplasia (commonly known as dwarfism), to manage health risks such as heart disease. By better understanding how body size could change how the body processes food, or how being bigger or smaller may influence eating habits, healthy living guidelines to tackle issues such as obesity and overweight in these populations can be improved. With help from expertise in the psychology field, this research will also investigate whether the mental health of these individuals has been affected by their size. On the whole, this study will involve one 24-hour visit to a research laboratory at the University of Bath, followed by a 2-week monitoring period to capture 'normal' physical activity and eating routines.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-07.
Status change: Recruiting → Active, Not Recruiting 2025-02-05
Trial Details
NCT Number NCT05991609
Lead Sponsor University of Bath
Collaborators: University of Bristol
Conditions Skeletal Dysplasia
Enrollment 102 participants
Start Date 2023-06-17
Primary Completion 2025-09-30 (estimated)
Study Completion 2035-09-28 (estimated)
Updated on ClinicalTrials.gov 2025-02-10